Skip to main content

Medical Oncology

Ausgabe 5/2014

Inhalt (38 Artikel)

Original Paper

Influence of CYP1A1, GST polymorphisms and susceptibility risk of chronic myeloid leukemia in Syrian population

Walid Al-Achkar, Ghassan Azeiz, Faten Moassass, Abdulsamad Wafa

Original Paper

c-Myc-induced, long, noncoding H19 affects cell proliferation and predicts a poor prognosis in patients with gastric cancer

Er-Bao Zhang, Liang Han, Dan-Dan Yin, Rong Kong, Wei De, Jinfei Chen

Original Paper

Genetic variations in MTHFR and esophageal squamous cell carcinoma susceptibility in Chinese Han population

Weifeng Tang, Sheng Zhang, Hao Qiu, Lixin Wang, Bin Sun, Jun Yin, Haiyong Gu

Original Paper

Expression of CD147 and Lewis y antigen in ovarian cancer and their relationship to drug resistance

Jian Gao, Zhenhua Hu, Juanjuan Liu, Dawo Liu, Yanyan Wang, Mingbo Cai, Danye Zhang, Mingzi Tan, Bei Lin

Original Paper

Clinical significance of Wnt-11 and squamous cell carcinoma antigen expression in cervical cancer

Heng Wei, Ning Wang, Yao Zhang, Shizhuo Wang, Xiaoao Pang, Jing Zhang, Qingshuang Luo, Youbo Su, Shulan Zhang

Original Paper

miR-99a and -99b inhibit cervical cancer cell proliferation and invasion by targeting mTOR signaling pathway

Li Wang, Lihua Chang, Zhaorong Li, Qing Gao, Dongge Cai, Yingfang Tian, Lingxia Zeng, Mu Li

Original Paper

Is it important to maintain high-dose intensity chemotherapy in the treatment of adults with osteosarcoma?

I. Kushnir, Y. Kolander, J. Bickels, Y. Gortzak, G. Flusser, J. Issakov, O. Merimsky

Original Paper

Down-regulation of Dicer expression in cervical cancer tissues

Hongqin Zhao, Xiance Jin, Huafang Su, Xia Deng, Ya Fang, Lanxiao Shen, Congying Xie

Original Paper

Expression of cytoskeleton regulatory protein Mena in human hepatocellular carcinoma and its prognostic significance

Kunpeng Hu, Jiani Wang, Zhicheng Yao, Bo Liu, Yuan Lin, Lei Liu, Lihua Xu

Original Paper

Expression and prognostic significance of livin/BIRC7 in childhood acute lymphoblastic leukemia

Lamia Ibrahim, Doaa Aladle, Ahmed Mansour, Ayman Hammad, Angi Adel Al Wakeel, Suzy A Abd El-Hameed

Original Paper

No association between XRCC3 Thr241Met and XPD Lys751Gln polymorphisms and the risk of colorectal cancer in West Algerian population: a case–control study

Fatima Zohra Moghtit, Meriem Samia Aberkane, Valérie Le Morvan, Lotfi Louhibi, Ricardo Bellot, Abdelkader Bousahba, Ahlem Megaiz, Mostefa Fodil, Sounnia Mediene-Benchekor, Faouzia Zemani-Fodil, Abdallah Boudjema, Jacques Robert, Nadhira Saidi-Mehtar

Original Paper

Risk of colorectal cancer among long-term cervical cancer survivors

Ana M. Rodriguez, Yong-Fang Kuo, James S. Goodwin

Original Paper

Delta-like ligand 4 (DLL4) in the plasma and neoplastic tissues from breast cancer patients: correlation with metastasis

Emmanuel Kontomanolis, Marianthi Panteliadou, Alexandra Giatromanolaki, Stamatia Pouliliou, Eleni Efremidou, Vassilios Limberis, Georgios Galazios, Efthimios Sivridis, Michael I. Koukourakis

Original Paper

Safety and efficacy of sorafenib in the treatment of advanced hepatocellular carcinoma: a single center experience

Esteban Rodrigo Imedio, Roberto Díaz Beveridge, Jorge Aparicio Urtasun, Gema Bruixola Campos, David Lorente Estellés, María Fonfría Esparcia, Javier Caballero Daroqui, Ángel Segura Huerta, Alejandra Giménez Órtiz, Joaquin Montalar Salcedo

Open Access Original Paper

Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa

Original Paper

Exhaled breath temperature in NSCLC: Could be a new non-invasive marker?

Giovanna E. Carpagnano, Donato Lacedonia, Antonio Spanevello, Domenico Martinelli, Valerio Saliani, Cinzia Ruggieri, Maria P. Foschino-Barbaro

Original Paper

Circulating levels of soluble Fas ligand reflect disease progression in multiple myeloma

Michael G. Alexandrakis, Constantina A. Pappa, Anna Kolovou, Stavroula Kyriakaki, Rodanthi Vyzoukaki, Maria Devetzoglou, George Tsirakis

Original Paper

3020insC NOD2/CARD15 polymorphism associated with treatment of colorectal cancer

Inés Omrane, Amel Mezlini, Olfa Baroudi, Nejla Stambouli, Karim Bougatef, Hager Ayari, Imen Medimegh, Hassen Bouzaienne, Nancy Uhrhammer, Yves-Jean Bignon, Amel Benammar-Elgaaied, Raja Marrakchi

Original Paper

EYA1 expression in gastric carcinoma and its association with clinicopathological characteristics: a pilot study

Parvaneh Nikpour, Modjtaba Emadi-Baygi, Elaheh Emadi-Andani, Shima Rahmati

Original Paper

On the status of β-cell dysfunction and insulin resistance of breast cancer patient without history of diabetes after systemic treatment

Lin-jie Lu, Lu Gan, Jin-bo Hu, Liang Ran, Qing-feng Cheng, Rui-jue Wang, Liang-bin Jin, Guo-sheng Ren, Hong-yuan Li, Kai-nan Wu, Ling-quan Kong

Original Paper

The impact of functional LIG4 polymorphism on platinum-based chemotherapy response and survival in non-small cell lung cancer

You-Hua Jiang, Xiao-Ling Xu, Hai-Hong Ruan, Wei-Zhen Xu, Dan Li, Jian-Guo Feng, Qian-Bo Han, Wei-Min Mao

Original Paper

Vasohibin-1 expression detected by immunohistochemistry correlates with prognosis in non-small cell lung cancer

Tao Zhang, Ting-Ting Yu, Dong-Ming Zhang, Xiao-Ming Hou, Xiao-Jun Liu, Da Zhao, Li Shan

Open Access Review Article

Bendamustine-based therapy as first-line treatment for non-Hodgkin lymphoma

Lidia Gil, Maciej Kazmierczak, Renata Kroll-Balcerzak, Mieczyslaw Komarnicki

Short Communication

Mantle cell lymphoma harboring Burkitt’s-like translocations presents differential expression of aurora kinase genes compared with others 8q abnormalities

Fábio Morato de Oliveira, Ana Paula Nunes Rodrigues-Alves, Antônio Roberto Lucena-Araújo, Ferdinando de Paula Silva, Fernanda Borges da Silva, Roberto Passetto Falcão

Short Communication

Dose adjustment of carboplatin in patients on peritoneal dialysis

Achuta K. Guddati, Parijat S. Joy, Creticus P. Marak

Short Communication

The expression analysis of LATS2 gene in de novo AML patients

Milad Gholami, Reza Mirfakhraie, Abolfazl Movafagh, Hasan Jalaeekhoo, Ramezanali Kalahroodi, Davood Zare-Abdollahi, Shohreh Zare-Karizi

Letter to the Editor

Very rare diseases in oncology

Petr Szturz

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.